We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$156M
1-Year Est. Return
14.89%
This Fund
S&P 500
This Quarter
Est. Return
+11.11%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$585M
AUM Growth
+$56.2M
(+11%)
Cap. Flow
+$17.6M
Cap. Flow
% of AUM
3.01%
Top 10 Holdings %
Top 10 Hldgs %
17.05%
Holding
830
New
329
Increased
104
Reduced
143
Closed
252
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$33.9M |
| 2 |
Verizon
VZ
|
+$6.56M |
| 3 |
Lowe's Companies
LOW
|
+$6.21M |
| 4 |
Procter & Gamble
PG
|
+$6.15M |
| 5 |
Danaher
DHR
|
+$5.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$12.8M |
| 2 |
Meta Platforms (Facebook)
META
|
+$11.3M |
| 3 |
Apple
AAPL
|
+$11.1M |
| 4 |
UnitedHealth
UNH
|
+$9.36M |
| 5 |
McCormick & Company Non-Voting
MKC
|
+$6.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.76% |
| 2 | Consumer Discretionary | 14.7% |
| 3 | Healthcare | 14.64% |
| 4 | Consumer Staples | 12.4% |
| 5 | Miscellaneous | 11.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
SPX Corp
SPXC
$10.3B
| $715K | 0.12% |
+14,062
| New | +$643K |
|
227
ICU Medical
ICUI
$4.38B
| $714K | 0.12% |
+3,817
| New | +$657K |
|
228
Intercontinental Exchange
ICE
$90.5B
| $713K | 0.12% |
+7,700
| New | +$715K |
|
229
Ingredion
INGR
$6.53B
| $706K | 0.12% |
+7,600
| New | +$639K |
|
230
Itron
ITRI
$4.35B
| $705K | 0.12% |
8,400
-700
| -8% | -$55.1K |
|
|
APHA
231
DELISTED
Aphria Inc. Common Shares
APHA
| $703K | 0.12% |
134,700
+82,100
| +156% | +$403K |
|
232
Viasat
VSAT
$10B
| $702K | 0.12% |
9,586
-3,700
| -28% | -$265K |
|
233
iShares Core US Aggregate Bond ETF
AGG
$139B
| $683K | 0.12% |
+6,077
| New | +$685K |
|
234
Lennar Class A
LEN
$20.5B
| $683K | 0.12% |
+12,647
| New | +$721K |
|
235
Cardlytics
CDLX
$23.6M
| $680K | 0.12% |
+1,081
| New | +$529K |
|
236
Restaurant Brands International
QSR
$27.2B
| $679K | 0.12% |
+10,650
| New | +$713K |
|
237
State Street SPDR S&P Biotech ETF
XBI
$11.7B
| $675K | 0.12% |
7,100
-7,200
| -50% | -$623K |
|
238
Paycom
PAYC
$10.7B
| $671K | 0.11% |
2,533
+1,333
| +111% | +$315K |
|
239
NIO
NIO
$10.9B
| $670K | 0.11% |
+166,700
| New | +$335K |
|
240
Helen of Troy
HELE
$674M
| $665K | 0.11% |
3,700
-600
| -14% | -$96.2K |
|
241
Novartis
NVS
$294B
| $663K | 0.11% |
6,998
-20,600
| -75% | -$1.85M |
|
242
Maximus
MMS
$3.12B
| $662K | 0.11% |
8,900
+1,900
| +27% | +$143K |
|
|
SCS
243
DELISTED
Steelcase
SCS
| $661K | 0.11% |
+32,313
| New | +$599K |
|
|
DISCK
244
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $660K | 0.11% |
21,635
-22,065
| -50% | -$619K |
|
|
SFIX
245
Stitch Fix
SFIX
$412M
| $659K | 0.11% |
+25,700
| New | +$597K |
|
246
BlackLine
BL
$1.96B
| $655K | 0.11% |
+12,700
| New | +$634K |
|
247
Copa Holdings
CPA
$5.36B
| $653K | 0.11% |
6,038
-4,643
| -43% | -$484K |
|
|
AZPN
248
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $653K | 0.11% |
5,397
-5,503
| -50% | -$666K |
|
249
Zumiez
ZUMZ
$298M
| $649K | 0.11% |
18,800
+5,400
| +40% | +$171K |
|
250
US Foods
USFD
$23.3B
| $647K | 0.11% |
15,456
+5,550
| +56% | +$223K |
|
Similar funds
MCM
MFG
AFW
ADBIC
HSM
FWM
PIA
CCP
Bayesian Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Bayesian Capital Management held 830 positions worth $585M, up 11% from $529M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Bayesian Capital Management deployed $17.6M of net new capital in Q4 2019, opening 329 new positions and adding to 104 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 110,200 shares worth $35.5M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $11.3M trimmed.
- Bayesian Capital Management's largest Q4 2019 buy was State Street SPDR S&P 500 ETF Trust: 110,200 shares worth $35.5M.
- Bayesian Capital Management added most to Edwards Lifesciences in Q4 2019, an estimated $4.47M increase.
- Bayesian Capital Management's biggest Q4 2019 reduction was Meta Platforms (Facebook), cutting an estimated $11.3M.
- Bayesian Capital Management fully exited Accenture in Q4 2019, selling an estimated $12.8M.
- Bayesian Capital Management's ten largest holdings make up 17% of its $585M portfolio in Q4 2019.
- Bayesian Capital Management opened 329 new positions and closed 252 in Q4 2019.
- Bayesian Capital Management's portfolio value rose 11% quarter-over-quarter to $585M.
Based on Bayesian Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.